Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package
Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company's acquisition by Merck KGaA of Darmstadt, Germany.
Bio-Techne Corp (TECH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HBK Investments David Costen Haley | 6,825,000 | $482,186,250 | 4.68% | |
| 2. | Whitebox Advisors Andy Redleaf | 2,100,001 | $148,365,071 | 1.94% | |
| 3. | Maverick Capital Lee Ainslie | 1,535,610 | $108,490,847 | -68% | 0.96% |
| 4. | Millennium Management Israel Englander | 989,033 | $69,875,181 | 0.03% | |
| 5. | Citadel Investment Group Ken Griffin | 965,918 | $68,242,106 | +2126% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $352.55 | 300 | $105,765.00 | 10,106 | 2022-05-10 | Filing | |
| $185.00 | 100 | $18,500.00 | 100 | 2019-09-09 | Filing | |
| $185.00 | 100 | $18,500.00 | 100 | 2019-09-09 | Filing | |
| $191.06 | 500 | $95,530.00 | 8,726 | 2019-08-07 | Filing | |
| $65.00 | 2,361 | $153,465.00 | 70,000 | 2013-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $48.28 | 6,636 | $320,386.08 | 200 | 2026-05-08 | Filing | |
| $59.11 | 1,976 | $116,791.48 | 200 | 2026-02-17 | Filing | |
| $56.36 | 17,040 | $960,388.03 | 44,559 | 2025-08-25 | Filing | |
| $56.21 | 17,040 | $957,818.40 | 44,863 | 2025-08-25 | Filing | |
| $49.77 | 1,280 | $63,704.83 | 1,976 | 2025-06-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 69,072 | $5,005,648 | 0.01% | |
| 2. | 44,986 | $3,260,135 | 0.02% | |
| 3. | 37,505 | $2,717,987 | 0.14% | |
| 4. | 27,580 | $1,998,723 | 0.2% | |
| 5. | 27,291 | $1,977,779 | 0.76% |
News See All
Investors' Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
9 Stocks Winning by Double Digits
Nine stocks clocked strong double-digit gains on Thursday, bucking a lackluster performance in the broader market, thanks to stellar earnings performance and acquisition news that sparked buying appetite...
Billionaire Larry Robbins’ 10 Dividend Stock Picks
In this article, we will take a look at the Billionaire Larry Robbins’ 10 Dividend Stock Picks.
Is Bio-Techne Corporation (TECH) A Good Stock To Buy Now?
Is TECH a good stock to buy? We came across a bullish thesis on Bio-Techne Corporation on r/ValueInvesting by Dynaheir-be. In this article, we will summarize the bulls’ thesis on TECH.
Baron Asset Fund Sold Bio-Techne Corporation (TECH) Due to Concerns Over Potential Impact of AI
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Asset Fund”. A copy of the letter is available to download here. U.S.
Bio-Techne Corporation (NASDAQ:TECH) Q3 2026 Earnings Call Transcript
Bio-Techne Corporation (NASDAQ:TECH) Q3 2026 Earnings Call Transcript May 6, 2026Bio-Techne Corporation misses on earnings expectations. Reported EPS is $0.53 EPS, expectations were $0.55.
What Makes Bio-Techne Corporation (TECH) a Good Investment?
Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for “Madison Mid Cap Fund”. A copy of the letter can be downloaded here.
Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections
Bio-Techne Corporation (NASDAQ:TECH) is one of the 10 best life sciences stocks to buy according to hedge funds.
10 Best Life Sciences Stocks to Buy According to Hedge Funds
Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.